Impaired fasting glucose (IFG) and impaired glucose intolerance (IGT) are predictors of cardiovascular disease (CVD). We tested the hypothesis that epicardial fat thickness (EFT) and carotid intima–media thickness (cIMT), as markers of early atherosclerosis, are increased in patients with prediabetes. We prospectively enrolled 246 patients (162 with prediabetes and 84 controls). Prediabetes was defined according to American Diabetes Association criteria, and patients were divided into 3 groups: group 1—IFG, group 2—IGT, and group 3—IFG + IGT. Both cIMT and EFT were significantly greater in patients with prediabetes compared with controls (0.81 ± 0.20 mm vs 0.68 ± 0.16 mm, P < .001 and 7.0 ± 2.0 mm vs 5.6 ± 1.6 mm, P < .001, respectively). This difference was mainly attributed to patients with IGT. Age, waist circumference, and 2-hour glucose independently predicted cIMT, while 2-hour glucose was the only independent predictor of EFT in multivariate analysis among other relevant parameters for cIMT and EFT. The cIMT and EFT (measured noninvasively) could be useful indicators of CVD risk in these patients. In order to prove this hypothesis, long-term prospective studies with greater patient numbers are required.
HuxleyRBarziFWoodwardM. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–78.
2.
The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality, comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–404.
3.
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(suppl 1):8–16.
4.
RydénLStandlEBartnikM. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. Eur Heart J. 2007;28(1):88–136.
5.
NicholsGAHillierTABrownJB. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care. 2007;30(2):228–233.
6.
Abdul-GhaniMAWilliamsKDeFronzoRSternM. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006;29(7):1613–1618.
7.
CarpenterMSinclairHKunadianV. Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiol Rev. 2016;24(2):70–75.
8.
NaqviTZLeeMS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7(10):1025–1038.
9.
SengulCOzverenO. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anadolu Kardiyol Derg. 2013;13(3):261–265.
10.
GastaldelliABastaG. Ectopic fat and cardiovascular disease: what is the link?Nutr Metab Cardiovasc Dis. 2010;20(7):481–490.
11.
IacobellisGLeonettiF. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab. 2005;90(11):6300–6302.
12.
AhnSGLimHSJoeDY. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94(3):e7.
13.
NabatiMSaffarNYazdaniJParsaeeMS. Relationship between epicardial fat measured by echocardiography and coronary atherosclerosis: a single-blind historical cohort study. Echocardiography. 2013;30(5):505–511.
14.
SengulCCevikCOzverenO. Epicardial fat thickness is associated with non-dipper blood pressure pattern in patients with essential hypertension. Clin Exp Hypertens. 2012;34(3):165–170.
15.
ArpaciDUgurluBPAslanANErsoyRAkcayMCakirB. Epicardial fat thickness in patients with prediabetes and correlation with other cardiovascular risk markers. Intern Med. 2015;54(9):1009–1014.
16.
KarbekBCakalECakirE. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism. Minerva Endocrinol. 2013;38(3):297–304.
17.
IacobellisGBarbaroGGersteinHC. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol. 2008;128(3):424–426.
18.
PerkJDe BackerGGohlkeH. European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–1701.
19.
LangRMBadanoLPMor-AviV. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.
GrundySMBrewerHBJrCleemanJI. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13–e18.
22.
ManciaGFagardRNarkiewiczK. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.
23.
LimTKLimEDwivediGKoonerJSeniorR. Normal value of carotid intima-media thickness: a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr. 2008;21(2):112–116.
24.
MostazaJMLahozCSalinero-FortMA; SPREDIA-2 Group. Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study. Atherosclerosis. 2015;242(2):377–382.
25.
IacobellisG. Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine. 2014;46(1):8–15.
26.
MarchingtonJMMattacksCAPondCM. Adipose tissue in the mammalian heart and pericardium: structure, fetal development and biochemical properties. Comp Biochem Physiol B. 1989;94(2):225–232.
27.
YasudaTMatsuhisaMFujikiN. Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?Endocr J. 2007;54(5):695–702.
28.
NataleFTedescoMAMocerinoR. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr. 2009;10(4):549–555.
29.
AydinHToprakADeyneliO. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat Disord. 2010;8(3):229–234.
30.
KimSKParkSWKimSHChaBSLeeHCChoYW. Visceral fat amount is associated with carotid atherosclerosis even in type 2 diabetic men with a normal waist circumference. Int J Obes. 2009;33(1):131–135.
31.
SengulCCevikCOzverenO. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography. 2011;28(8):853–858.
32.
NelsonMRMookadamFThotaV. Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?J Am Soc Echocardiogr. 2011;24(3):339–345.
33.
KesselsKCramerMJVeldhuisB. Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease. Heart. 2006;92(7):262.
34.
IacobellisG. Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr Drug Targets Cardiovasc Hematol Dis. 2005;5(4):345–353.
35.
PickupJC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–823.
36.
FrostegårdJ. Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol. 2013;4:162.
37.
The Emerging Risk Factors Collaboration. C-Reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320.
38.
RidkerPMRifaiNStampferMJHennekensCH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101(15):1767–1772.
39.
ErogluSSadeLEPolatEBozbasHUlusTMuderrisogluH. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology. 2011;62(2):107–110.
40.
FeigDIKangDHJohnsonRJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821.
41.
SuccurroEMariniMAGrembialeA. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes Metab Res Rev. 2009;25(4):351–356.
42.
HanefeldMKoehlerCHenkelEFueckerKSchaperFTemelkova-KurktschievT. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med. 2000;17(12):835–840.
43.
QiaoQPyoralaKPyoralaM. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002;23(16):1267–1275.
44.
NingFTuomilehtoJPyöräläKOnatASöderbergSQiaoQ; DECODE Study Group. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care. 2010;33(10):2211–2216.
